Completed OBSERVATIONAL NCT02694367

Expression of EPK in Recurrent Miscarriage (EPK-RM)

MAP Kinase Signaling Pathways Through ERK and p-ERK Protein in Human Placenta of Women With Recurrent Miscarriage

Sponsor: Assiut University

Interventions Investigate the MAP kinase signaling pathways through ERK and p-ERK proteins

Updated 7 times since 2017 Last updated: Feb 26, 2016 Started: Jan 31, 2015 Primary completion: Dec 31, 2015 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Recurrent Miscarriage, this trial is completed. The trial is conducted by Assiut University and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Assiut, Egypt